ANDREWS DEBORAH J 4
4 · Lineage Cell Therapeutics, Inc. · Filed Jul 1, 2021
Insider Transaction Report
Form 4
ANDREWS DEBORAH J
Director
Transactions
- Award
Stock Option (right to buy)
2021-07-01+50,000→ 50,000 totalExercise: $2.86Exp: 2031-07-01→ Common Shares (50,000 underlying)
Footnotes (1)
- [F1]Will vest and become exercisable on July 1, 2022, subject to the reporting person's continuous service with the issuer.